Written testimony before the Committee on Transportation and Infrastructure, U.S. House of Representatives, the Committee on Commerce, Science and Transportation, U.S. Senate, and the Committee on the Judiciary, U.S. House of Representatives on antitrust aspects of U.S. shipping laws
This event has already occurred.
Related Insights
Amgen Files Three New Prolia® / Xgeva® BPCIA Litigations Against Hikma, Shanghai Henlius Biotech, and Biocon’s Proposed Biosimilars